Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C137818
http://purl.obolibrary.org/obo/NCIT_C137818
|
|---|---|
| Preferred Name | Androgen Receptor Antagonist TAS3681 |
| Definitions |
An orally bioavailable inhibitor of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR inhibitor TAS3681 specifically binds to AR. This prevents AR activation, downregulates AR and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally bioavailable inhibitor of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR inhibitor TAS3681 specifically binds to AR. This prevents AR activation, downregulates AR and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells. |
|---|---|
| prefLabel | Androgen Receptor Antagonist TAS3681
|
| label | Androgen Receptor Antagonist TAS3681
|
| NCI_META_CUI | CL524893
|
| PDQ_Closed_Trial_Search_ID | 789958
|
| code | C137818
|
| prefixIRI | NCIT:C137818
|
| in_subset | |
| Preferred_Name | Androgen Receptor Antagonist TAS3681
|
| Maps_To | Androgen Receptor Antagonist TAS3681
|
| NCI_Drug_Dictionary_ID | 789958
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 789958
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |